On the stock market since 1998, it operates in the world of health and science. It has 5 employees. Now — the numbers.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
Nothing in the current numbers stands out as a strong positive. That, by itself, is worth knowing.
The stock sits at $0.0001. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
On our five-subject report card, RCPIQ sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: RCPIQ is a high-risk stock — not yet profitable, and its future rides on its product catching on.